It also seek to confirm its impact and the associated mechanism on the anti-PD-1/PD-L1 immunotherapy in bladder cancer, employing an animal model of FMT and mono-colonization with P. distasonis. This evidence concerns the gene PDCD1 and urinary bladder carcinoma.